|
LONP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.482200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.262600E-01 |
| Normal-vs-Stage2 |
8.512300E-02 |
| Normal-vs-Stage3 |
6.283800E-01 |
| Normal-vs-Stage4 |
9.955400E-01 |
| Stage1-vs-Stage2 |
2.373000E-01 |
| Stage1-vs-Stage3 |
6.010200E-02 |
| Stage1-vs-Stage4 |
3.403000E-01 |
| Stage2-vs-Stage3 |
3.241600E-02 |
| Stage2-vs-Stage4 |
1.013200E-01 |
| Stage3-vs-Stage4 |
6.431000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.153800E-01 |
| Normal-vs-AfricanAmerican |
5.412300E-02 |
| Normal-vs-Asian |
4.969000E-01 |
| Caucasian-vs-AfricanAmerican |
1.225570E-01 |
| Caucasian-vs-Asian |
8.258800E-01 |
| AfricanAmerican-vs-Asian |
2.109000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.594800E-01 |
| Normal-vs-Female |
1.542000E-01 |
| Male-vs-Female |
1.853740E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.930950E-01 |
| Normal-vs-Age(41-60Yrs) |
5.609000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.563000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.839440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.667000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.193000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.209820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.577200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.798790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.774970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.814800E-01 |
| Classical-VS-Follicular |
3.324000E-01 |
| Classical-VS-Other |
1.491990E-01 |
| Classical-VS-Normal |
1.328980E-01 |
| Tall-VS-Follicular |
6.528200E-01 |
| Tall-VS-Other |
2.962600E-01 |
| Tall-VS-Normal |
9.338400E-01 |
| Follicular-VS-Other |
2.985400E-01 |
| Follicular-VS-Normal |
6.718600E-01 |
| Other-VS-Normal |
2.536800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.222800E-01 |
| Normal-vs-N1 |
7.598000E-01 |
| N0-vs-N1 |
4.009600E-01 |
|
|
